About Oxford Expression Technologies
Oxford Expression Technologies is a company based in Oxford (United Kingdom) founded in 2006. The company has 30 employees as of October 31, 2022. Oxford Expression Technologies offers products and services including flashBAC™, Transfer Vectors, and Insect Cells. Oxford Expression Technologies operates in a competitive market with competitors including Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others.
- Headquarter Oxford, United Kingdom
- Employees 30 as on 31 Oct, 2022
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oxford Expression Technologies Limited
- Date of Incorporation 12 Jul, 2006
- Jurisdiction OXFORD, OXFORDSHIRE
-
Annual Revenue
Not available
-
Net Profit
$550.9 K (USD)-26as on Oct 31, 2022
-
EBITDA
Not available
-
Latest Funding Round
$270.5 K (USD), Grant
Nov 18, 2016
- Investors
-
Employee Count
30
as on Oct 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oxford Expression Technologies
Oxford Expression Technologies offers a comprehensive portfolio of products and services, including flashBAC™, Transfer Vectors, and Insect Cells.
Kit for producing superior recombinant protein yields via baculovirus.
Vectors used for gene expression in insect cell systems.
Cells like Sf9 for protein production and viral titration.
Funding Insights of Oxford Expression Technologies
Investors in Oxford Expression Technologies
Oxford Expression Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gov.uk.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Online government services and information are provided to users.
|
Locked | Locked | Locked |
Investor details for Oxford Expression Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oxford Expression Technologies
Investment portfolio details for Oxford Expression Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oxford Expression Technologies
Detailed financials for Oxford Expression Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oxford Expression Technologies Comparisons
Peer comparison for Oxford Expression Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oxford Expression Technologies
Oxford Expression Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
UBaaS platform for plant-based recombinant protein bioproduction is offered.
|
|
| Locked | Locked | Locked |
Animal-free growth factors are developed for life science applications.
|
|
| Locked | Locked | Locked |
Serum-free bioactive growth factors and recombinant proteins are biomanufactured.
|
|
| Locked | Locked | Locked |
Protein-based enzyme technologies are developed using deep learning algorithms.
|
|
| Locked | Locked | Locked |
Biopharmaceuticals and proteins are developed using green plants as hosts.
|
|
| Locked | Locked | Locked |
Developer of recombinant biologics for animal and human health
|
Detailed competitors of Oxford Expression Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oxford Expression Technologies
Complete news archive for Oxford Expression Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxford Expression Technologies
Oxford Expression Technologies was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Oxford Expression Technologies is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
As of Oct 31, 2022, the latest employee count at Oxford Expression Technologies is 30.
Oxford Expression Technologies was founded in 2006 in Oxford, United Kingdom, within the biotechnology sector. Reagents for protein expression and cell culture are developed, with products encompassing BaculoVirus system-based items, insect cell culture media, and recombinant proteins. Services include mammalian cell protein expression, baculovirus production, and insect cell-based recombinant protein manufacturing, supporting research and development operations.
Oxford Expression Technologies's top competitors include Future Fields, Qkine and Core Biogenesis.
Oxford Expression Technologies offers flashBAC™, Transfer Vectors, and Insect Cells.
Oxford Expression Technologies has 1 investor. Key investors include Gov.uk.
The valuation of Oxford Expression Technologies is $1.89M as of Dec 2008.